| Primary |
| Hypertension |
19.6% |
| Upper Respiratory Tract Infection |
19.6% |
| Vitamin Supplementation |
19.6% |
| Peritoneal Dialysis |
13.7% |
| Anaemia |
3.9% |
| Anticoagulant Therapy |
3.9% |
| Drug Use For Unknown Indication |
3.9% |
| Erectile Dysfunction |
3.9% |
| Hyperparathyroidism |
3.9% |
| Hyperphosphataemia |
3.9% |
| Infusion Site Infection |
3.9% |
|
| Dehydration |
66.7% |
| Peritonitis Sclerosing |
33.3% |
|
| Secondary |
| Peritoneal Dialysis |
60.9% |
| Product Used For Unknown Indication |
15.4% |
| Renal Failure Chronic |
8.4% |
| Wegener's Granulomatosis |
2.1% |
| Tremor |
1.7% |
| Drug Use For Unknown Indication |
1.5% |
| Antiinflammatory Therapy |
1.2% |
| Hypovitaminosis |
1.2% |
| Diabetic Nephropathy |
1.0% |
| Diabetes Mellitus |
0.7% |
| Electrolyte Imbalance |
0.6% |
| Anticoagulant Therapy |
0.6% |
| Blood Pressure |
0.6% |
| Cardiac Disorder |
0.6% |
| Chest Pain |
0.6% |
| Diuretic Therapy |
0.6% |
| Gastric Disorder |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Muscle Spasms |
0.6% |
| Pain |
0.6% |
|
| Death |
47.7% |
| Sepsis |
7.3% |
| Peritonitis |
5.2% |
| Cerebrovascular Accident |
4.7% |
| Peritonitis Bacterial |
4.7% |
| Pyrexia |
4.4% |
| Noninfectious Peritonitis |
2.6% |
| Infectious Peritonitis |
2.3% |
| Peritoneal Cloudy Effluent |
2.3% |
| Cardiac Failure |
2.0% |
| Epistaxis |
2.0% |
| Myocardial Infarction |
2.0% |
| Pneumonia |
2.0% |
| Haemorrhagic Anaemia |
1.7% |
| Peritoneal Fluid Analysis Abnormal |
1.7% |
| Cardiovascular Disorder |
1.5% |
| Choking |
1.5% |
| Infection |
1.5% |
| Ischaemic Stroke |
1.5% |
| Malaise |
1.5% |
|
| Concomitant |
| Peritoneal Dialysis |
87.9% |
| Diabetes Mellitus |
5.2% |
| Fluid Overload |
5.2% |
| Drug Use For Unknown Indication |
1.7% |
|
| Hypoglycaemia |
38.9% |
| Peritonitis |
27.8% |
| Respiratory Arrest |
16.7% |
| Grand Mal Convulsion |
5.6% |
| Pharmaceutical Product Complaint |
5.6% |
| Urinary Tract Infection |
5.6% |
|
